Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA
- 26 June 2019
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 57 (1) , 128-143
Abstract
Allergen immunotherapy (AIT) for allergic rhinitis (AR), asthma, and other allergic diseases has developed quickly. House dust mite (HDM), Artemisia (wormwood), Humulus japonicus (Japanese hop), Alternaria alternata, and Cladosporium herbarum are the five most common inhalant allergens in China. AIT has been performed in China for over 60 years. With the support of the Chinese Medical Association (CMA) and the Chinese Medical Doctors Association (CMDA), the Chinese College of Allergy and Asthma (CCAA) was established in 2016 as a specialized branch of CDMA and is the main certification authority for AIT. Chinese allergists and scientists have made tremendous progress in the development of AIT. There have been many publications by Chinese allergists and scientists worldwide encompassing original research studies, systematic reviews, case studies, and clinical trials. Currently, conventional subcutaneous immunotherapy (SCIT) is the preferred AIT in China, but sublingual immunotherapy (SLIT) is beginning to gain recognition. An increasing number of clinical trials have been conducted to investigate the clinical efficacy and side effects of SLIT and SCIT. In China, HDM is the only commercial standardized allergen extracts in clinical use, whereas the others are crude allergen extracts. Besides standardized allergen extracts, other forms of hypoallergenic extracts are still being investigated and developed in China. Immunotherapy in China is similar to that in the USA in which allergen extracts can be mixed for SCIT. However, allergen extracts cannot be mixed for SCIT in Europe.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (CIFMS:2016-I2M-1-003)
- National Natural Science Foundation of China (81571568)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 74 references indexed in Scilit:
- Clinical efficacy and compliance of sublingual immunotherapy with Dermatophagoides farinae drops in patients with atopic dermatitisInternational Journal of Dermatology, 2013
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine deliveryNanoscale, 2013
- Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needsJournal of Allergy and Clinical Immunology, 2012
- Prevention of oral food allergy sensitization via skin application of food allergen in a mouse modelAllergy, 2012
- Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: A multicenter studyBMC Public Health, 2011
- 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)Allergy, 2011
- Self-reported prevalence of childhood allergic diseases in three cities of China: a multicenter studyBMC Public Health, 2010
- The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America surveyAllergy and Asthma Proceedings, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Progress in research on pharmaceutics for intranasal medicationJournal of Chinese Integrative Medicine, 2004